House Speaker Plans Vote on Biosecure Act Amid Broader China Legislation Push

1. House Speaker Mike Johnson plans to bring the Biosecure Act to a vote in the fall as part of a broader package of legislation aimed at countering China's influence.
2. The Biosecure Act targets Chinese biotech companies, including WuXi AppTec and Beijing Genomics Institute, by halting federal contracts with firms "beholden to adversaries" that endanger Americans' healthcare data.
3. Johnson aims to have a significant package of China-related legislation signed into law by the end of 2024, which includes the Biosecure Act and other measures to strengthen the domestic economy, improve defense infrastructure, and use economic power to influence partner nations and counter adversaries.
4. The Biosecure Act was introduced by Reps. Mike Gallagher (R-Wis.) and Raja Krishnamoorthi (D-Ill.) in January 2024 and has been welcomed by the chair of the Select Committee on the CCP, Rep. John Moolenaar (R-Mich.).
5. The bill has already impacted American biotech companies, with a survey showing a 30-50% reduction in confidence among U.S.-based life science companies working with China-based firms.